查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1982866

全球药品安全监测市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Pharmacovigilance Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 228 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计药品安全监测市场将从 2025 年的 89.4 亿美元成长到 2034 年的 164.4 亿美元，2026 年至 2034 年的复合年增长率为 7.01%。

随着製药业日益重视药物安全和监测，全球药物安全监测市场正迅速扩张。药物安全监测是指药物相关不利事件进行检测、评估及预防。这在确保患者安全和维持药物整个生命週期的合规性方面发挥着至关重要的作用。

多种因素正在推动药物安全监测市场的成长。临床试验和新核准药物数量的增加，推动了上市后监测和安全监控的需求。监管机构也在实施严格的安全指南，要求製药公司密切监测不利事件。此外，现代药物疗法的日益复杂化，也使得先进的药物安全监测系统变得愈发重要。

随着医疗保健系统持续将病人安全放在首位，药物安全监测市场前景十分光明。数据分析、人工智慧和数位健康技术的进步正在提高安全监测流程的效率。随着全球医药创新不断拓展，药物安全监测仍将是药物研发和医疗保健监管中不可或缺的重要组成部分。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球药品安全监测市场：依产品生命週期划分

  • 市场分析、洞察与预测
  • 临床前
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第五章 全球药品安全监测市场：依服务供应商

  • 市场分析、洞察与预测
  • 内部结构
  • 外包

第六章 全球药品安全监测市场：依类型划分

  • 市场分析、洞察与预测
  • 自愿报告
  • 加强ADR报告
  • 有针对性的自愿报告
  • 伫列事件监测
  • 电子健康记录挖掘

第七章 全球药品安全监测市场：依最终用途划分

  • 市场分析、洞察与预测
  • 製药
  • 生技公司
  • 医疗设备製造商
  • 其他的

第八章 全球药物安全监测市场：依治疗领域划分

  • 市场分析、洞察与预测
  • 肿瘤学
  • 神经病学
  • 循环系统
  • 呼吸系统
  • 其他的

第九章 全球药品安全监测市场：依流程划分

  • 市场分析、洞察与预测
  • 案例资料管理
  • 医学审查和报告
  • 讯号检测
  • 风险管理系统

第十章 全球药品安全监测市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第十一章 竞争格局

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第十二章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Accenture
    • IQVIA Inc
    • Cognizant
    • Clinquest Group BV（Linical Americas）
    • IBM
    • Laboratory Corporation Of America Holdings
    • ArisGlobal
    • Capgemini
    • ITClinical
    • ICON Plc
    • TAKE Solutions Limited
    • Parexel International（MA）Corporation
    • Wipro
    • United BioSource LLC
    • BioClinica Inc.（Clario）
    • ClinChoice（Formerly FMD K&L）
简介目录
Product Code: VMR11212767

The Pharmacovigilance Market size is expected to reach USD 16.44 Billion in 2034 from USD 8.94 Billion (2025) growing at a CAGR of 7.01% during 2026-2034.

The global pharmacovigilance market is expanding rapidly as the pharmaceutical industry places greater emphasis on drug safety and monitoring. Pharmacovigilance involves the detection, assessment, and prevention of adverse effects related to pharmaceutical products. It plays a critical role in ensuring patient safety and maintaining regulatory compliance throughout the lifecycle of a drug.

Several factors are driving the growth of the pharmacovigilance market. The increasing number of clinical trials and newly approved drugs is creating a greater need for post-marketing surveillance and safety monitoring. Regulatory authorities are also implementing strict safety guidelines that require pharmaceutical companies to monitor adverse drug reactions carefully. Additionally, the growing complexity of modern drug therapies is increasing the importance of advanced pharmacovigilance systems.

The future outlook for the pharmacovigilance market is highly promising as healthcare systems continue to prioritize patient safety. Advances in data analytics, artificial intelligence, and digital health technologies are improving the efficiency of safety monitoring processes. As pharmaceutical innovation continues to expand globally, pharmacovigilance will remain a crucial component of drug development and healthcare regulation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Life Cycle

  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Service Provider

  • In-house
  • Contract Outsourcing

By Type

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

By End Use

  • Pharmaceuticals
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Others

By Therapeutic Area

  • Oncology
  • Neurology
  • Cardiology
  • Respiratory Systems
  • Others

By Process Flow

  • Case Data Management
  • Medical Reviewing & Reporting
  • Signal Detection
  • Risk Management System

COMPANIES PROFILED

  • Accenture, IQVIA Inc, Cognizant, Clinquest Group BV Linical Americas, IBM, Laboratory Corporation of America Holdings, ArisGlobal, Capgemini, ITClinical, ICON plc, TAKE Solutions Limited, Parexel International MA Corporation, Wipro, United BioSource LLC, BioClinica Inc Clario, ClinChoice formerly FMD KL
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACOVIGILANCE MARKET: BY PRODUCT LIFE CYCLE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Life Cycle
  • 4.2. Pre-clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Phase I Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Phase II Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Phase III Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Phase IV Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACOVIGILANCE MARKET: BY SERVICE PROVIDER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Service Provider
  • 5.2. In-house Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Contract Outsourcing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACOVIGILANCE MARKET: BY TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Type
  • 6.2. Spontaneous Reporting Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Intensified ADR Reporting Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Targeted Spontaneous Reporting Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Cohort Event Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. EHR Mining Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACOVIGILANCE MARKET: BY END USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End Use
  • 7.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Medical Device Manufacturers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PHARMACOVIGILANCE MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Therapeutic Area
  • 8.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Respiratory Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PHARMACOVIGILANCE MARKET: BY PROCESS FLOW 2022-2034 (USD MN)

  • 9.1. Market Analysis, Insights and Forecast Process Flow
  • 9.2. Case Data Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.3. Medical Reviewing & Reporting Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.4. Signal Detection Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.5. Risk Management System Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL PHARMACOVIGILANCE MARKET: BY REGION 2022-2034(USD MN)

  • 10.1. Regional Outlook
  • 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.2.1 By Product Life Cycle
    • 10.2.2 By Service Provider
    • 10.2.3 By Type
    • 10.2.4 By End Use
    • 10.2.5 By Therapeutic Area
    • 10.2.6 By Process Flow
    • 10.2.7 United States
    • 10.2.8 Canada
    • 10.2.9 Mexico
  • 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.3.1 By Product Life Cycle
    • 10.3.2 By Service Provider
    • 10.3.3 By Type
    • 10.3.4 By End Use
    • 10.3.5 By Therapeutic Area
    • 10.3.6 By Process Flow
    • 10.3.7 United Kingdom
    • 10.3.8 France
    • 10.3.9 Germany
    • 10.3.10 Italy
    • 10.3.11 Russia
    • 10.3.12 Rest Of Europe
  • 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.4.1 By Product Life Cycle
    • 10.4.2 By Service Provider
    • 10.4.3 By Type
    • 10.4.4 By End Use
    • 10.4.5 By Therapeutic Area
    • 10.4.6 By Process Flow
    • 10.4.7 India
    • 10.4.8 Japan
    • 10.4.9 South Korea
    • 10.4.10 Australia
    • 10.4.11 South East Asia
    • 10.4.12 Rest Of Asia Pacific
  • 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.5.1 By Product Life Cycle
    • 10.5.2 By Service Provider
    • 10.5.3 By Type
    • 10.5.4 By End Use
    • 10.5.5 By Therapeutic Area
    • 10.5.6 By Process Flow
    • 10.5.7 Brazil
    • 10.5.8 Argentina
    • 10.5.9 Peru
    • 10.5.10 Chile
    • 10.5.11 South East Asia
    • 10.5.12 Rest of Latin America
  • 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.6.1 By Product Life Cycle
    • 10.6.2 By Service Provider
    • 10.6.3 By Type
    • 10.6.4 By End Use
    • 10.6.5 By Therapeutic Area
    • 10.6.6 By Process Flow
    • 10.6.7 Saudi Arabia
    • 10.6.8 UAE
    • 10.6.9 Israel
    • 10.6.10 South Africa
    • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

  • 11.1. Recent Developments
  • 11.2. Company Categorization
  • 11.3. Supply Chain & Channel Partners (based on availability)
  • 11.4. Market Share & Positioning Analysis (based on availability)
  • 11.5. Vendor Landscape (based on availability)
  • 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL PHARMACOVIGILANCE INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Company Profiles
    • 12.2.1 Accenture
    • 12.2.2 IQVIA Inc
    • 12.2.3 Cognizant
    • 12.2.4 Clinquest Group B.V. (Linical Americas)
    • 12.2.5 IBM
    • 12.2.6 Laboratory Corporation Of America Holdings
    • 12.2.7 ArisGlobal
    • 12.2.8 Capgemini
    • 12.2.9 ITClinical
    • 12.2.10 ICON Plc
    • 12.2.11 TAKE Solutions Limited
    • 12.2.12 Parexel International (MA) Corporation
    • 12.2.13 Wipro
    • 12.2.14 United BioSource LLC
    • 12.2.15 BioClinica Inc. (Clario)
    • 12.2.16 ClinChoice (Formerly FMD K&L)